Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Acute Heart Failure: Reality and Recommendations

05.09.2005


The number of hospitalizations for heart failure is about the same as for acute myocardial infarction.



Our knowledge over acute heart failure patients treated at hospitals for heart failure is based on surveys. In Europe the information is still scarce but emerging especially through the European Society of Cardiology (ESC) Euroheart survey program.

In the Euroheart Heart Failure I survey performed in 2000, which collected information from 10701 patients treated by heart failure medication particularly diuretics on emergency basis and onward found out that 47% of the patients were females and 51% of them were over 75 years old. In male subjects, 30% were older than 75 years. As stated, the number of hospitalizations for heart failure is about the same as for acute myocardial infarction and moreover 30% of acute coronary syndrome patients have mild or severe heart failure.


In Euroheart II, which is a European survey on characteristics of acute heart failure in Europe, 40% of unselected patient population are females. In female acute heart failure patients the prevalence of acute new onset heart failure is 44% and higher than in male subjects. The female subjects are older with mean age of 73 years compared to 68 years in male subjects.

During the last decade, heart failure has received increased attention due to the cost of care for the society. The hospitalizations are long from 3 – 21 days depending on the severity, mean 9 days, including at least one day in intensive care or corresponding specialty care units with higher cost. The mean cost can be an estimated 3000€ per hospitalization without special investigations.

Out of the acute heart failure patients 60% have known heart failure and 40% are patients with acute cardiac emergency causing heart failure. Thirty-five percent of patients undergo cardiac catheterization and interventions are frequent, especially in patients who present with acute and new heart failure as many of these are caused by acute coronary syndrome.

Mortality is high, in hospital 7% and during three-month follow up 10%. The mortality in cardiogenic shock patients is 70 – 80%.

The ESC has recently in January 2005 issued European guidelines on acute heart failure, which institutes the definition and classification of acute heart failure and delineates our current evidence and expert opinion on acute heart failure therapy. The ongoing Euroheart survey elucidates the causes and treatment of acute heart failure and in its ongoing follow-up the therapy after hospitalization as well as prognosis.

There are several complicating factors in the course of our patients. Seventeen percent of females have anemia, partly related to age. Thirty-one percent have atrial arrythmias, especially atrial fibrillation. Some of the patients have ventricular tachycardias or life threatening arrythmias. In male subjects history of smoking is frequent and they often have more chronic lung diseases. Eight percent of patients have pneumonia at entry. Renal insufficiency, usually mild is frequent, with 16%. Diabetes is complicating the course in 34% of females and 30% of male subjects. New research is warranted and needed and in the future our treatment practises should be evaluated with proper research.

Heart failure patients are “a country” in Europe, there are so many. Acute heart failure hospitalizations are as frequent as myocardial infarction and moreover it is complicating many of our coronary patients. ESC guidelines will standardize the care of acute heart failure patients, but fresh research and development of medical care is welcome to improve the prognosis and to lower the cost.

Gina Dellios | alfa
Further information:
http://www.escardio.org/vpo/ESC_congress_information/ConferenceReleases/

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>